Oral tolerisation to pyruvate dehydrogenase complex as a potential therapy for primary biliary cirrhosis

Autoimmunity

Volumn 35, Issue 8, 2002, Pages 537-544

  Jones, David E J ^a   Palmer, Jeremy M ^a   Robe, Amanda ^a   Kirby, John A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Autoimmunity; Mouse; Spleen; T lymphocytes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; PYRUVATE DEHYDROGENASE COMPLEX; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG TOLERANCE; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INTRAHEPATIC BILE DUCT; LIVER HISTOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; SENSITIZATION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER CIRRHOSIS, BILIARY; MICE; PYRUVATE DEHYDROGENASE COMPLEX; T-LYMPHOCYTES;

EID: 0036940723     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693021000054084     Document Type: Article

References (52)

1. Neuberger, J.M. (1997) "Primary biliary cirrhosis", Lancet 350, 875-879.
2. Yeaman, S.J., Kirby, J.A. and Jones, D.E.J. (2000) "Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis", Immunol. Rev. 174, 238-249.
3. Palmer, J.M., Bassendine, M.F., James, O.F.W. and Yeaman, S.J. (1993) "Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis", Clin. Sci. 85, 289-293.
4. Jones, D.E.J., Palmer, J.M., Yeeman, S.J., Bassendine, M.F. and Diamond, A.G. (1997) "T-cell responses to natural human proteins in primary biliary cirrhosis", Clin. Exp. Immunol. 116, 562-568.
5. Palmer, J.M., Kirby, J.A. and Jones, D.E.J. (2002) "Primary biliary cirrhosis: The end of the beginning", Clin. Exp. Immunol. 129, 191-197.
6. Kita, H., Lian, Z., Van De Water, J., He, X., Matsumura, S., Kaplan, M., et al. (2002) "Identification of HLA-A2-restricted CD8+ cytotoxic T-cell responses in primary biliary cirrhosis: T-cell activation is augmented by immune complexes cross-presented by dendritic cells", J. Exp. Med. 195, 113-123.
7. Kita, H., Matsumura, S., He, X., Ansari, A., Lian, Z., Van De Water, J., et al. (2002) "Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis", J. Clin. Investig. 109, 1231-1240.
8. Bjorkland, A., Festin, R., Mendel-Hartvig, I., Nyberg, A., Loff, L. and Totterman, T. (1991) "Blood and liver infiltrating lymphocytes in primary biliary cirrhosis: Increase in activated T and natural killer cells and recruitment of primed memory T-cells", Hepatology 13, 1106-1111.
9. Harada, K., Ozaki, S., Gershwin, M.E. and Nakanuma, Y. (1997) "Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis", Hepatology 26, 1399-1405.
10. Tinmouth, J., Lee, M., Wanless, I.R., Tsui, F.W.L., Inman, R. and Heathcote, E.J. (2002) "Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis", Liver 22, 228-234.
11. Beuers, U. (1999) "Primary biliary cirrhosis: Treatments other than ursodeoxycholic acid", (West End Studios, Eastbourne), Primary Biliary Cirrhosis pp. 115-118.
12. Mitchision, H.C., Palmer, J.M., Bassendine, M.F., Watson, A.J., Bassendine, M.F., Watson, A.J., et al. (1992) "A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results", J. Hepatol. 15, 336-344.
13. Jones, D.E.J., James, O.F.W. and Bassendine, M.F. (1998) "Primary biliary cirrhosis: Clinical and associated autoimmune features and natural history", Clin. Liver Dis. 2, 265-282.
14. Strobel, S. and Mowat, A.M. (1999) "Immune responses to dietary antigens: Oral tolerance", Immunol. Today 19, 173-181.
15. Weiner, H.L. (1997) "Oral tolerance: Immune mechanisms and treatment of autoimmune diseases", Immunol. Today 18, 335-343.
16. Garside, P. and Mowat, A.M. (1997) "Mechanisms of oral tolerance", Crit. Rev. Immunol. 17, 119-137.
17. Bitar, D.M. and Whitacre, C.C. (1988) "Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein", Cell Immunol. 112, 364-370.
18. Elson, C.O., Beagley, K.W., Sharmanov, A.T., Fujiashi, K., Kiyonon, H., Tennyson, G.S., et al. (1996) "Hapten-induced model of murine inflammatory bile disease-mucosal immune responses and protection by tolerance", J. Immunol. 157, 2174-2185.
19. He, Y.G., Mellon, J. and Niederkorn, J.Y. (1996) "The effect of oral immunization on corneal allograft survival", Transplantation 61, 920-926.
20. Jones, D.E.J., Palmer, J.M., Yeaman, S.J., Kirby, J.A. and Bassendine, M.F. (1999) "Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis a murine model of primary biliary cirrhosis", Hepatology 30, 65-70.
21. Jones, D.E.J., Palmer, J.M., Kirby, J.A., De Cruz, D.J., McCaughan, G.W., Sedgewick, J.D., et al. (2000) "Experimental autoimmune cholangitis: A mouse model of immune-mediated cholangiopathy", Liver 20, 351-356.
22. Jones, D.E.J., Palmer, J.M., Bennett, K., Robe, A.J., Yeamam, S.J., Robertson, H., et al. (2002) "Investigation of a mechanism for accelerated breakdown of immune-tolerance to the primary biliary cirrhosis associated autoantigen, pyruvate dehydrogenase complex", Lab. Investig. 82, 211-219.
23. Jones, D.E.J., Palmer, J.M., Burt, A.D., Robe, A.J. and Kirby, J.A. (2002) "Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex", Hepatology 36, 679-686.
24. Jones, D.E.J., Palmer, J.M., Yeaman, SJ., James, O.F.W., Bassendine, M.F. and Diamond, A.G. (1995) "T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis", Hepatology 21, 995-1002.
25. Stanley, C.J. and Perham, R.N. (1980) "Purification of the 2-oxo acid dehydrogenase complexes from ox heart by a new method", Biochem. J. 191, 147-154.
26. Yeaman, S.J., Fussey, S.P., Danner, D.J., James, O.F.W., Mutimer, D.J. and Bassendine, M.F. (1998) "Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens", Lancet, 1067-1070.
27. Coppel, R.L., McNeilage, L.J., Surh, C.D., Van De Water, J., Spithill, I.W., Whittingham, S., et al. (1988) "Primary structure of the human M2 mitochondrial autoantigen in primary biliary cirrhosis", Proc. Natl Acad. Sci. USA 85, 7317-7321.
28. Fussey, S.P.M., Guest, J.R., James, O.F.W., Bassendine, M.F. and Yeaman, S.J. (1988) "Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis", Proc. Natl Acad. Sci. (USA) 85, 8654-8658.
29. Van De Water, J., Gershwin, M.E., Leung, P.S.C. and Coppel, R.L. (1988) "The autoepitope of the 74 KD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase", J. Exp. Med. 167, 1791-1799.
30. Van De Water, J., Fregeau, D., Davis, P., Ansari, A., Danner, D., Leung, P., et al. (1988) "Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function", J. Immunol. 141, 2321-2324.
31. Mutimer, D.J., Fussey, S.P., Yeaman, S.J., Kelly, P.J., James, O.F.W. and Bassendine, M.F. (1989) "Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis", Hepatology 10, 403-407.
32. Fussey, S.P.M., Ali, S.T., Guest, J.R., James, O.F.W., Bassendine, M.F. and Yeaman, S.J. (1990) "Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): Characterisation of the main immunogenic region", Proc. Natl Acad. Sci. (USA) 87, 3987-3991.
33. Van De Water, J., Ansari, A.A., Surh, C.D., Coppel, R., Roche, T., Donkovsky, H.B., et al. (1991) "Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T-cell response of primary biliary cirrhosis", J. Immunol. 146, 89-94.
34. Lohr, H., Fleischer, B., Gerken, G., Yeaman, S.J., MzB, K.H. and Manns, M. (1993) "Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognise inner mitochondrial epitopes and the pyruvate dehydrogenase complex", J. Hepatol. 18, 322-327.
35. Van De Water, J., Ansari, A., Prindiville, T., Coppel, R.L., Ricalton, N., Kotzin, B.L., et al. (1995) "Heterogeneity of autoreactive T-cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis", J. Exp. Med. 181, 723-733.
36. Shimoda, S., Nakamura, M., Ishibashi, H., Hayashida, K. and Niho, Y. (1995) "HLA DRB4 0101-resticted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: Evidence of molecular mimicry in human autoimmune disease", J. Exp. Med. 181, 1835-1845.
37. Shimoda, S., Van De Water, J., Ansari, A., Nakamura, M., Ishibashi, H., Coppel, R.L., et al. (1998) "Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis", J. Clin. Investig. 102, 1831-1840.
38. Mitchison, H.C., Bassendine, M.F., Hendrick, A., Bennett, M.K., Bird, A.G., Watson, A.J.B., et al. (1986) "Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis?", Hepatology 6, 1279-1284.
39. Metcalf, J.V., Mitchinson, H.C., Palmer, J.M., Jones, D.E.J., Bassendine, M.F. and James, O.F.W. (1996) "Natural history of early primary biliary cirrhosis", Lancet 348, 1399-1402.
40. Berg, P.A., Klein, R. and Rocken, M. (1997) "Cytokines in primary biliary cirrhosis", Semin. Liver Dis. 17, 115-123.
41. Harada, K., Van De Water, J., Leung, P.S., Coppel, R.L., Ansari, A.A., Nakanuma, Y., et al. (1997) "In situ nucleic acid hybridisation of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset", Hepatology 25, 791-796.
42. Liblau, R.S., Singer, S.M. and McDevitt, H.O. (1995) "Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases", Immunol. Today 16, 34-38.
43. Abbas, A.K., Murphy, K.M. and Sher, A. (1996) "Functional diversity of helper T lymphocytes", Nature 383, 787-793.
44. Weiner, H.L. (2001) "Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells", Immunol. Rev. 182, 207-214.
45. Zhang, X., Izikson, L., Liu, L. and Weiner, H.L. (2001) "Activation of CD25(+)CD4(+) regulatory cells by oral antigen administration", J. Immunol. 167, 4245-4253.
46. Weiner, H.L. (2000) "Oral tolerance, an active immunologic process mediated by multiple mechanisms", J. Clin. Investig. 106, 935-937.
47. Chen, Y., Inobe, J. and Weiner, H.L. (1997) "Inductive events in oral tolerance in the TCR transgenic adoptive transfer model", Cell Immunol. 178, 62-68.
48. Gautam, S.C., Chikkala, N.F. and Battisto, J.R. (1990) "Oral administration of the contact sensitiser trinitrochlorobenzene: Initial sensitisation and subsequent appearance of a suppressor population", Cell Immunol. 125, 437-438.
49. Sasaki, M., Long, S.A., Van De Water, J., He, X-S., Shultz, L., Coppel, R.L., et al. (2002) "The SJL/J mouse is not a model for PBC", Hepatology 35, 1284.
50. Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S. and Elson, C.O. (1994) "Oral tolerance in humans: T-cell but not B-cell tolerance after antigen feeding", J. Immunol. 152, 4663-4670.
51. Postlethwaite, A.E. (2001) "Can we induce tolerance in rheumatoid arthritis?", Curr. Rheum. Rep. 3, 64-69.
52. Gale, E.A.M. (2000) "Oral tolerance and autoimmune diabetes-will hope triumph over experience?", Lancet 356, 526-527.